Additionally, ONOO-induced post-translational modifications impair the activities of both GCL and GSH synthetase, further reducing GSH synthesis [122]
Di VincenzoFDel GaudioAPetitoVLopetusoLRScaldaferriF
Performance Sleep, Performance Dose 20 units (1mg Tesamorelin / 200mcg Ipamorelin) Frequency 5 days / week Administration Subcutaneous Timing PM, 60-90 minutes after last meal, close to bedtime Vial Size 12mg (10mg Tesamorelin / 2mg Ipamorelin) Reconstitution 2mL Bacteriostatic Water Cycle Length 3 months on, 2 months off Vials / Month 2 Vials / Cycle 6 Do not combine with other GH-stimulating peptides such as CJC-1295/Ipamorelin
Development and FDA Approval The development of Sermorelin arose from research in the 1970s-1980s that characterized GHRH structure, function, and identified that the biologically active portion responsible for GH-releasing activity resides in the N-terminal region of the molecule, specifically amino acids 1-29, while the C-terminal portion (amino acids 30-44) is not required for receptor binding or signaling
It is also studied for effects on inflammation balance and oxidative stress, which can influence how skin looks and feels over time
